CA-GENOLOGICS
GenoLogics today announced the availability of Clarity LIMS X, an edition of its industry-leading laboratory informatics platform. Optimized for use with Illumina® SeqLab, the X Edition of Clarity LIMS provides positive sample tracking, maximizes quality and throughput, and improves turnaround time in population-scale genomics workflows.
The 2014 launch of the HiSeq X systems enabled labs to break the $1,000 barrier for human whole-genome sequencing. Labs are now addressing how to scale to groundbreaking throughput while maintaining a focus on quality and accuracy. The X Edition provides rapid scaling with automation and business logic built into preconfigured HiSeq X Series workflows. Samples advance through the pipeline automatically, minimizing human interaction and the potential for error while enforcing quality standards. The X Edition of Clarity LIMS was designed based upon best practices from Genomics England Lab (GEL) and the Illumina FastTrack Services Lab , and is currently in use in both labs.
Clarity LIMS X Edition also provides e-signature, audit trails, and patient data security, making it suitable for regulated environments. According to Illumina Director of Scientific Research, Ryan Taft, Ph.D., “Clarity LIMS X closes the gap in providing a commercially available LIMS that includes out of the box instrument integration and positive sample tracking.”
“We are proud to partner with Illumina to provide the X Edition of Clarity LIMS for Illumina SeqLab,” says Michael Ball, CEO of GenoLogics. He adds, “This solution empowers scientists and clinicians to advance the understanding of disease and accelerate the integration of genomics into everyday healthcare.”
About GenoLogics
GenoLogics develops the industry-leading laboratory information management system (LIMS) for life sciences organizations. All Clarity LIMS editions help labs gain efficiencies and throughput with increased accuracy, fast turnaround, sample traceability, and preconfigured instrument integrations. Whether labs are regulated or unregulated, big or small, Clarity LIMS streamlines operations so that life sciences organizations can focus on advancing healthcare. In 2014, GenoLogics was independently awarded the Frost & Sullivan Customer Leadership Award in the area of Next Generation Sequencing Informatics. Founded in 2002 and privately held, GenoLogics has offices in Canada, U.S., and Europe. www.genologics.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20150721005207/en/
Contact:
GenoLogics Life Sciences Software
Lisa Owen, +1-250-483-7011
Communications
Manager
lisa.owen@genologics.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
IFF Completes Divestiture of Pharma Solutions Business Unit1.5.2025 08:00:00 CEST | Press release
IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its Pharma Solutions business unit to Roquette. “The completion of our Pharma Solutions divestiture represents a significant milestone for IFF as we delivered our targeted net debt to credit-adjusted EBITDA of below 3.0x,” said Erik Fyrwald, IFF CEO. “This is an important step as it allows us to focus on our core strategy – capitalizing on the exciting growth opportunities within our key businesses – as we maximize long-term value for our shareholders. We’d like to thank our Pharma Solutions colleagues for their unwavering commitment and their dedication to exceptional customer service. We wish them continued success as they find a new home with Roquette.” Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that
More Impact, Together: Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 20251.5.2025 08:00:00 CEST | Press release
Varian, a Siemens Healthineers company, will showcase an integrated portfolio designed to streamline workflows, and aiming to enhance patient experience and improve patient outcomes from screening to survivorship at the 2025 European Society for Radiotherapy and Oncology (ESTRO) annual meeting, May 2-6, in Vienna, Austria. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430039992/en/ At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our pers
REI Super Selects SS&C For Superannuation Administration1.5.2025 05:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that REI Super (“REI”), the superannuation fund for Australia’s real estate industry, has signed a long-term agreement to partner with SS&C. REI selected SS&C to serve as the fund’s administrator following a competitive tender process. SS&C Global Investor & Distribution Solutions (GIDS) will provide REI with superannuation administration services and streamlined operations support to its 24,000 members across Australia. REI will benefit from SS&C’s local administration expertise, supported by its global investment in digital service channels, automation and artificial intelligence to enhance the member experience. “As one of Australia’s longest-standing superannuation funds, our focus has always been on serving our members,” said Jarrod Coysh, CEO of REI Super. “SS&C’s extensive track record in fund administration and innovative technology make them the ideal operations partner to help us best meet our members’ needs.” “W
Svante and Mercer International Advance Carbon Capture Project at Alberta Pulp Mill1.5.2025 03:25:00 CEST | Press release
Svante Technologies Inc. (Svante), a leader in carbon capture and removal technology, today announced that its joint carbon capture and storage project with Mercer International Inc. (Mercer) has advanced to the Front-end Engineering and Design Phase 2 (FEL-2). Also known as Pre-FEED, this phase involves engineering, cost estimation, and risk analysis to evaluate the project's commercial viability. Mercer is a global producer of sustainably sourced forest products, including pulp, lumber, mass timber, biomass-based green energy, and bioextractives. The carbon capture project targets biogenic CO2 emissions from Mercer’s Peace River pulp mill, where the biomass (fibre) is sourced from sustainably managed forests. Advancing to the Pre-FEED stage will support further development of the integrated design, cost estimates, and risk assessments—key steps toward a final investment decision and potential implementation. This milestone reflects the growing momentum for carbon capture solutions wi
Andersen Global udvider sin europæiske værdiansættelseskapacitet gennem samarbejde med Value & Risk Valuation Services1.5.2025 03:03:00 CEST | Pressemeddelelse
Andersen Global fortsætter med at styrke sin værdiansættelseskapacitet gennem en samarbejdsaftale med Value & Risk Valuation Services, et fremtrædende europæisk værdiansættelsesfirma med hovedsæde i Tyskland og kontorer i Luxembourg og Østrig. Value & Risk Valuation Services blev grundlagt i 1996 og er et ledelsesejet firma, der har specialiseret sig i værdiansættelse af finansielle aktiver på tværs af forskellige aktivklasser og med varierende kompleksitet. Firmaet leverer også supplerende tjenester, herunder uafhængig prisverifikation (IPV), risikoanalyse og analyse af transaktionsomkostninger. Siden 2009 har virksomheden været ledet af Gil Bender, som er dedikeret til at levere kundecentrerede værdiansættelsesløsninger af høj kvalitet. Som en af de få europæiske udbydere, der tilbyder eksterne værdiansættelsestjenester i overensstemmelse med det europæiske direktiv om forvaltere af alternative investeringsfonde (AIFMD), opretholder Value & Risk de højeste industristandarder for over
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum